Log in to save to my catalogue

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9637534

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

About this item

Full title

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2022-12, Vol.40 (52), p.7579-7585

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•There have been conflicting reports regarding a temporal association between COVID-19 vaccination and Guillain-Barré Syndrome (GBS). •This case series from Victoria, Australia, reports an excess of GBS cases following dose 1 of the adenovirus-vector COVID-19 vaccine Vaxzevria ChadOx1-S (AstraZeneca). •Global collaborative studies are req...

Alternative Titles

Full title

Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9637534

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9637534

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2022.10.084

How to access this item